These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 23359095)
21. Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men. Sun H; Kennedy WP; Wilbraham D; Lewis N; Calder N; Li X; Ma J; Yee KL; Ermlich S; Mangin E; Lines C; Rosen L; Chodakewitz J; Murphy GM Sleep; 2013 Feb; 36(2):259-67. PubMed ID: 23372274 [TBL] [Abstract][Full Text] [Related]
22. Can the Orexin Antagonist Suvorexant Preserve the Ability to Awaken to Auditory Stimuli While Improving Sleep? Drake CL; Kalmbach DA; Cheng P; Roth T; Tran KM; Cuamatzi-Castelan A; Atkinson R; Singh M; Tonnu CV; Fellman-Couture C J Clin Sleep Med; 2019 Sep; 15(9):1285-1291. PubMed ID: 31538599 [TBL] [Abstract][Full Text] [Related]
23. First-in-class insomnia drug on the brink of approval nod. Osborne R Nat Rev Drug Discov; 2013 Jul; 12(7):492-3. PubMed ID: 23812257 [No Abstract] [Full Text] [Related]
24. Mechanism of action of suvorexant. Stahl SM CNS Spectr; 2016 Jun; 21(3):215-8. PubMed ID: 27322687 [TBL] [Abstract][Full Text] [Related]
25. Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in rats. Whitman DB; Cox CD; Breslin MJ; Brashear KM; Schreier JD; Bogusky MJ; Bednar RA; Lemaire W; Bruno JG; Hartman GD; Reiss DR; Harrell CM; Kraus RL; Li Y; Garson SL; Doran SM; Prueksaritanont T; Li C; Winrow CJ; Koblan KS; Renger JJ; Coleman PJ ChemMedChem; 2009 Jul; 4(7):1069-74. PubMed ID: 19418500 [TBL] [Abstract][Full Text] [Related]
26. Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia. Owen RT Drugs Today (Barc); 2016 Jan; 52(1):29-40. PubMed ID: 26937493 [TBL] [Abstract][Full Text] [Related]
27. Suvorexant for the treatment of insomnia. Jacobson LH; Callander GE; Hoyer D Expert Rev Clin Pharmacol; 2014 Nov; 7(6):711-30. PubMed ID: 25318834 [TBL] [Abstract][Full Text] [Related]
28. [Roles of orexin and effects of orexin receptor antagonists]. Sakurai T Nihon Rinsho; 2015 Jun; 73(6):1023-30. PubMed ID: 26065136 [TBL] [Abstract][Full Text] [Related]
29. Discovery of dual orexin receptor antagonists (DORAs) for the treatment of insomnia. Coleman PJ; Cox CD; Roecker AJ Curr Top Med Chem; 2011; 11(6):696-725. PubMed ID: 21261591 [TBL] [Abstract][Full Text] [Related]
30. Selective loss of GABA(B) receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Matsuki T; Nomiyama M; Takahira H; Hirashima N; Kunita S; Takahashi S; Yagami K; Kilduff TS; Bettler B; Yanagisawa M; Sakurai T Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4459-64. PubMed ID: 19246384 [TBL] [Abstract][Full Text] [Related]
31. Dual orexin receptor antagonists - promising agents in the treatment of sleep disorders. Pałasz A; Lapray D; Peyron C; Rojczyk-Gołębiewska E; Skowronek R; Markowski G; Czajkowska B; Krzystanek M; Wiaderkiewicz R Int J Neuropsychopharmacol; 2014 Jan; 17(1):157-68. PubMed ID: 23702225 [TBL] [Abstract][Full Text] [Related]
32. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation. Beuckmann CT; Yanagisawa M J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908 [TBL] [Abstract][Full Text] [Related]